Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T92966
|
|||||
Target Name |
Hepatocellular carcinoma-associated antigen 90 (TPX2)
|
|||||
Synonyms |
Restricted expression proliferation-associated protein 100; Protein fls353; Hepatocellular carcinoma-associated antigen 519; HCA519; Differentially expressed in cancerous and non-cancerous lung cells 2; DIL2; DIL-2; C20orf2; C20orf1
Click to Show/Hide
|
|||||
Gene Name |
TPX2
|
|||||
Target Type |
Literature-reported target
|
[1] | ||||
Function |
Spindle assembly factor required for normal assembly of mitotic spindles. Required for normal assembly of microtubules during apoptosis. Required for chromatin and/or kinetochore dependent microtubule nucleation. Mediates AURKA localization to spindle microtubules (PubMed:18663142, PubMed:19208764). Activates AURKA by promoting its autophosphorylation at 'Thr-288' and protects this residue against dephosphorylation (PubMed:18663142, PubMed:19208764). TPX2 is inactivated upon binding to importin-alpha (PubMed:26165940). At the onset of mitosis, GOLGA2 interacts with importin-alpha, liberating TPX2 from importin-alpha, allowing TPX2 to activates AURKA kinase and stimulates local microtubule nucleation (PubMed:26165940).
Click to Show/Hide
|
|||||
BioChemical Class |
TPX2 family
|
|||||
UniProt ID | ||||||
Sequence |
MSQVKSSYSYDAPSDFINFSSLDDEGDTQNIDSWFEEKANLENKLLGKNGTGGLFQGKTP
LRKANLQQAIVTPLKPVDNTYYKEAEKENLVEQSIPSNACSSLEVEAAISRKTPAQPQRR SLRLSAQKDLEQKEKHHVKMKAKRCATPVIIDEILPSKKMKVSNNKKKPEEEGSAHQDTA EKNASSPEKAKGRHTVPCMPPAKQKFLKSTEEQELEKSMKMQQEVVEMRKKNEEFKKLAL AGIGQPVKKSVSQVTKSVDFHFRTDERIKQHPKNQEEYKEVNFTSELRKHPSSPARVTKG CTIVKPFNLSQGKKRTFDETVSTYVPLAQQVEDFHKRTPNRYHLRSKKDDINLLPSKSSV TKICRDPQTPVLQTKHRARAVTCKSTAELEAEELEKLQQYKFKARELDPRILEGGPILPK KPPVKPPTEPIGFDLEIEKRIQERESKKKTEDEHFEFHSRPCPTKILEDVVGVPEKKVLP ITVPKSPAFALKNRIRMPTKEDEEEDEPVVIKAQPVPHYGVPFKPQIPEARTVEICPFSF DSRDKERQLQKEKKIKELQKGEVPKFKALPLPHFDTINLPEKKVKNVTQIEPFCLETDRR GALKAQTWKHQLEEELRQQKEAACFKARPNTVISQEPFVPKKEKKSVAEGLSGSLVQEPF QLATEKRAKERQELEKRMAEVEAQKAQQLEEARLQEEEQKKEELARLRRELVHKANPIRK YQGLEIKSSDQPLTVPVSPKFSTRFHC Click to Show/Hide
|
|||||
3D Structure | Click to Show 3D Structure of This Target | PDB |
Cell-based Target Expression Variations | Top | |||||
---|---|---|---|---|---|---|
Cell-based Target Expression Variations |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Adenosine monophosphate | Ligand Info | |||||
Structure Description | TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 8-34, and in complex with AMP-PNP | PDB:6VPM | ||||
Method | X-ray diffraction | Resolution | 1.58 Å | Mutation | No | [2] |
PDB Sequence |
MSYSYDAPSD
15 FINFSSKRQW128 ALEDFEIGRP138 LGKGKFGNVY148 LAREKQSKFI158 LALKVLFKAQ 168 LEKAGVEHQL178 RREVEIQSHL188 RHPNILRLYG198 YFHDATRVYL208 ILEYAPLGTV 218 YRELQKLSKF228 DEQRTATYIT238 ELANALSYCH248 SKRVIHRDIK258 PENLLLGSAG 268 ELKIADFGWS278 VHAPTLCGTL293 DYLPPEMIEG303 RMHDEKVDLW313 SLGVLCYEFL 323 VGKPPFEANT333 YQETYKRISR343 VEFTFPDFVT353 EGARDLISRL363 LKHNPSQRPM 373 LREVLEHPWI383 TANSSK
|
|||||
|
||||||
Ligand Name: Ammonia | Ligand Info | |||||
Structure Description | Crystal structure of Aurora-A bound to a hydrocarbon-stapled proteomimetic of TPX2 | PDB:5LXM | ||||
Method | X-ray diffraction | Resolution | 2.08 Å | Mutation | Yes | [3] |
PDB Sequence |
SSYSYDAPSD
15 FINFSSLTQN30 IDSWFEKANE42 N
|
|||||
|
||||||
Click to View More Binding Site Information of This Target with Different Ligands |
Different Human System Profiles of Target | Top |
---|---|
Human Similarity Proteins
of target is determined by comparing the sequence similarity of all human proteins with the target based on BLAST. The similarity proteins for a target are defined as the proteins with E-value < 0.005 and outside the protein families of the target.
A target that has fewer human similarity proteins outside its family is commonly regarded to possess a greater capacity to avoid undesired interactions and thus increase the possibility of finding successful drugs
(Brief Bioinform, 21: 649-662, 2020).
Human Tissue Distribution
of target is determined from a proteomics study that quantified more than 12,000 genes across 32 normal human tissues. Tissue Specificity (TS) score was used to define the enrichment of target across tissues.
The distribution of targets among different tissues or organs need to be taken into consideration when assessing the target druggability, as it is generally accepted that the wider the target distribution, the greater the concern over potential adverse effects
(Nat Rev Drug Discov, 20: 64-81, 2021).
Biological Network Descriptors
of target is determined based on a human protein-protein interactions (PPI) network consisting of 9,309 proteins and 52,713 PPIs, which were with a high confidence score of ≥ 0.95 collected from STRING database.
The network properties of targets based on protein-protein interactions (PPIs) have been widely adopted for the assessment of target’s druggability. Proteins with high node degree tend to have a high impact on network function through multiple interactions, while proteins with high betweenness centrality are regarded to be central for communication in interaction networks and regulate the flow of signaling information
(Front Pharmacol, 9, 1245, 2018;
Curr Opin Struct Biol. 44:134-142, 2017).
Human Similarity Proteins
Human Tissue Distribution
Biological Network Descriptors
|
There is no similarity protein (E value < 0.005) for this target
|
Note:
If a protein has TS (tissue specficity) scores at least in one tissue >= 2.5, this protein is called tissue-enriched (including tissue-enriched-but-not-specific and tissue-specific). In the plots, the vertical lines are at thresholds 2.5 and 4.
|
Degree | 32 | Degree centrality | 3.44E-03 | Betweenness centrality | 2.39E-04 |
---|---|---|---|---|---|
Closeness centrality | 2.15E-01 | Radiality | 1.38E+01 | Clustering coefficient | 6.31E-01 |
Neighborhood connectivity | 4.51E+01 | Topological coefficient | 1.50E-01 | Eccentricity | 13 |
Download | Click to Download the Full PPI Network of This Target | ||||
Target Regulators | Top | |||||
---|---|---|---|---|---|---|
Target-interacting Proteins |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer. Cancer Biol Ther. 2016 Aug 2;17(8):824-32. | |||||
REF 2 | Redox priming promotes Aurora A activation during mitosis. Sci Signal. 2020 Jul 21;13(641):eabb6707. | |||||
REF 3 | A TPX2 Proteomimetic Has Enhanced Affinity for Aurora-A Due to Hydrocarbon Stapling of a Helix. ACS Chem Biol. 2016 Dec 16;11(12):3383-3390. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.